Jubilant Ingrevia inks pact to acquire 100% stake in Remidex Pharma

14 Mar 2026 Evaluate

Jubilant Ingrevia has entered into the Share Purchase Agreement with Remidex Pharma (Remidex) for acquisition of its 100% stake. After acquisition Remidex will become wholly owned subsidiary of the Company. 

This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4). Cost of acquisition is Rs 16.5 crore subject to customary closing conditions. The said acquisition is expected to be completed in 30 days.  

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers. 


Jubilant Ingrevia Share Price

584.75 13.55 (2.37%)
20-Mar-2026 16:01 View Price Chart
Peers
Company Name CMP
BASF India 3304.00
Tata Chemicals 633.85
SRF 2454.50
Pidilite Inds. 1335.00
Deepak Nitrite 1390.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×